Dr. Gerald Diaz @GeraldMD
48.7M 14.2K 7.5K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
4 results
antiplatelet inhibitor p2y12 prasugrel switching ticagrelor cangrelor cardiology ddi drugdrug enteropathy herbal induced interactions medications olmesartan otc supplementals villousatrophy
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... Drug interactions ... Inhibitor #switching #conversion ... #Clopidogrel #plavix ... ticagrelor #prasugrel #pharmacology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... dose of a given drug ... dose of a given drug ... #Clopidogrel #plavix ... ticagrelor #prasugrel #pharmacology
Pharmaceutical agents other than olmesartan have been reported to cause villous atrophy on occasion and are
been reported to cause ... are listed in Table ... of drug-induced ... #Pharmacology #Drugs ... #Medications #Differential
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products Angiotensin-Converting Enzyme Inhibitors (ACEIs) • Night-blooming
Cardiovascular Drug-Drug ... Increases activity of clopidogrel ... vera, Licorice - Causes ... Antiarrhythmic Drugs ... #DDI #table #cardiology
empty